ACET's logo.
Ticker Symbol: ACET

Adicet Bio Inc

$9.36 - 09-10-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001720580

Company Profile

adicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs). adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and generating tcr-like mabs (tcrls) directed to these cancer-specific peptide targets presented by mhc class i complexes. these tcrls can be used to arm t cells, as t cell engagers or as antibody drug conjugates (adc). in august 2016, adicet entered a strategic collaboration with regeneron pharmaceuticals, inc. to develop next-generation engineered immune-cell therapeutics using adicet’s gamma delta t cell allogeneic platform technology. adicet bio raised $51m in series a financing led by orbimed partners, orbimed israel, novartis v

Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 500 Boylston St Fl 12
CEO: Chen Schor
Tags:
  • Distribution Services
  • Medical Distributors
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Medicinal and Botanical Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.50
Change: $0.04 ( 2.74%)
Days Range: $1.43 - $1.60
Beta: 0.79
52wk. High: $21.87
52wk. Low: $1.24
Ytd. Change -80.48%
50 Day Moving Average: $1.53
200 Day Moving Average: $3.58
Shares Outstanding: 43066158

Valuation

Market Cap: 6.5B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A